Inventor · Cambridge, MA, US

David Glass

44Patents
10h-index
78Co-inventors
78Inventor score

Filing activity: Nov 14, 1994 → Oct 12, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US9815901B2 Treatment of cancer using a CD123 chimeric antigen receptor Chemistry; Metallurgy 80 Active
US8481031B2 Methods and compositions using Klotho-FGF fusion polypeptides Chemistry; Metallurgy 42 Active
US8420088B2 Methods and compositions using FGF23 fusion polypeptides Chemistry; Metallurgy 41 Active
US8932589B2 Methods and compositions using Kloto-FGF23 fusion polypeptides Chemistry; Metallurgy 37 Active
US7355018B2 Modified IGF1 polypeptides with increased stability and potency Chemistry; Metallurgy 33 Expired
US10174095B2 Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 27 Active
US10287354B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 21 Active
US8158581B2 IGF-1 fusion polypeptides and therapeutic uses thereof Chemistry; Metallurgy 16 Active
US7396918B2 IGF-I fusion polypeptides and therapeutic uses thereof Chemistry; Metallurgy 11 Expired
US7521211B2 IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof Chemistry; Metallurgy 11 Active
US7837999B2 Method of increasing muscle mass with IGF-1 fusion polypeptides Chemistry; Metallurgy 10 Active
US8445434B2 IGF-1 fusion polypeptides and therapeutic uses thereof Chemistry; Metallurgy 10 Active
US10004803B2 Low, immune enhancing, dose mtor inhibitors and uses thereof Chemistry; Metallurgy 10 Active
US5814478A Tyrosine kinase receptors and ligands Human Necessities 9 Expired
US10286069B2 Low, immune enhancing, dose MTOR inhibitors and uses thereof Chemistry; Metallurgy 8 Active
US11084880B2 Anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 8 Active
US6143714A Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons Chemistry; Metallurgy 8 Expired
US5622862A Assay systems for trkB neurotrophin activity Physics 7 Expired
US10357514B2 Treatment of cancer using anti-CD19 Chimeric Antigen Receptor Chemistry; Metallurgy 7 Active
US6852838B2 Tyrosine kinase receptors and ligands Human Necessities 7 Expired
US7632503B2 Method of treating a muscle-related condition with modified IGF1 polypeptides Chemistry; Metallurgy 4 Active
US9365651B2 Method for treating metabolic disorders by administration of an anti-ActRIIB antibody Chemistry; Metallurgy 3 Active
US7781404B2 IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof Chemistry; Metallurgy 3 Active
US6413740B1 Tyrosine kinase receptors and ligands Human Necessities 3 Expired
US8343918B2 Stabilized insulin-like growth factor polypeptides Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.